Danaher Corporation $DHR Shares Sold by Huntington National Bank

Huntington National Bank lessened its stake in shares of Danaher Corporation (NYSE:DHR) by 14.2% during the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 48,524 shares of the conglomerate’s stock after selling 8,050 shares during the period. Huntington National Bank’s holdings in Danaher were worth $9,620,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also made changes to their positions in DHR. White Pine Capital LLC lifted its position in Danaher by 1.4% during the 2nd quarter. White Pine Capital LLC now owns 3,494 shares of the conglomerate’s stock worth $690,000 after acquiring an additional 49 shares during the period. SOL Capital Management CO raised its stake in shares of Danaher by 2.8% in the third quarter. SOL Capital Management CO now owns 1,829 shares of the conglomerate’s stock worth $363,000 after purchasing an additional 50 shares during the last quarter. Purkiss Capital Advisors LLC raised its stake in shares of Danaher by 3.9% in the third quarter. Purkiss Capital Advisors LLC now owns 1,327 shares of the conglomerate’s stock worth $263,000 after purchasing an additional 50 shares during the last quarter. TCTC Holdings LLC lifted its holdings in shares of Danaher by 0.7% during the third quarter. TCTC Holdings LLC now owns 7,439 shares of the conglomerate’s stock worth $1,475,000 after purchasing an additional 51 shares during the period. Finally, Howard Capital Management Group LLC boosted its position in Danaher by 4.8% in the third quarter. Howard Capital Management Group LLC now owns 1,159 shares of the conglomerate’s stock valued at $230,000 after buying an additional 53 shares during the last quarter. Hedge funds and other institutional investors own 79.05% of the company’s stock.

Danaher Trading Up 0.4%

Shares of Danaher stock opened at $210.28 on Friday. The firm has a 50-day simple moving average of $225.33 and a two-hundred day simple moving average of $216.23. The company has a debt-to-equity ratio of 0.35, a quick ratio of 1.51 and a current ratio of 1.87. Danaher Corporation has a fifty-two week low of $171.00 and a fifty-two week high of $242.80. The company has a market cap of $148.70 billion, a P/E ratio of 41.72, a price-to-earnings-growth ratio of 2.85 and a beta of 0.91.

Danaher (NYSE:DHR) last announced its quarterly earnings results on Tuesday, January 27th. The conglomerate reported $2.23 earnings per share for the quarter, beating the consensus estimate of $2.14 by $0.09. The firm had revenue of $6.84 billion during the quarter, compared to analyst estimates of $6.79 billion. Danaher had a return on equity of 10.81% and a net margin of 14.71%.Danaher’s revenue for the quarter was up 4.6% compared to the same quarter last year. During the same quarter in the previous year, the business earned $2.14 EPS. As a group, equities analysts predict that Danaher Corporation will post 7.63 earnings per share for the current fiscal year.

Danaher Increases Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, April 24th. Stockholders of record on Friday, March 27th will be paid a dividend of $0.40 per share. This represents a $1.60 annualized dividend and a dividend yield of 0.8%. The ex-dividend date of this dividend is Friday, March 27th. This is a positive change from Danaher’s previous quarterly dividend of $0.32. Danaher’s dividend payout ratio is currently 25.40%.

Analyst Ratings Changes

A number of equities analysts have issued reports on DHR shares. Wall Street Zen raised shares of Danaher from a “hold” rating to a “buy” rating in a research report on Saturday, November 22nd. Deutsche Bank Aktiengesellschaft reaffirmed a “buy” rating on shares of Danaher in a report on Thursday, January 29th. Wells Fargo & Company raised their target price on shares of Danaher from $230.00 to $240.00 and gave the stock an “equal weight” rating in a report on Monday, December 15th. Guggenheim boosted their target price on shares of Danaher from $250.00 to $275.00 and gave the company a “buy” rating in a research report on Friday, January 2nd. Finally, TD Cowen reaffirmed a “buy” rating on shares of Danaher in a research report on Wednesday, January 7th. Twenty analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the stock. According to data from MarketBeat.com, Danaher currently has a consensus rating of “Moderate Buy” and a consensus target price of $253.86.

Insider Activity

In other news, EVP Gregory M. Milosevich sold 1,320 shares of the stock in a transaction that occurred on Thursday, February 19th. The stock was sold at an average price of $208.01, for a total transaction of $274,573.20. Following the transaction, the executive vice president owned 5,099 shares in the company, valued at $1,060,642.99. This trade represents a 20.56% decrease in their position. The sale was disclosed in a filing with the SEC, which is available at the SEC website. 11.10% of the stock is owned by company insiders.

Danaher Company Profile

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.